News from vermillion, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:VRML)

09:00 ET

Vermillion Lands America's Most Decorated Gymnast and Ovarian Cancer Survivor, Shannon Miller, for its OVA1® Awareness Team

Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced the most decorated gymnast in...

Jan 19, 2016, 09:00 ET

Vermillion to Present at 7th Annual Life Science CEO Forum

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that it will present at...

Jan 11, 2016, 09:00 ET

Vermillion Exits 2015 with 33M Lives Covered for OVA1®

Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, exited 2015 with substantial coverage for its...

Dec 09, 2015, 13:19 ET

Vermillion to Host Key Opinion Leader Meeting to Discuss Advances in Ovarian Cancer Detection

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that it will host a...

Dec 01, 2015, 09:00 ET

Vermillion Announces Key Medical Policy Coverage by Medi-Cal for OVA1® Test

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced additional medical policy...

Nov 17, 2015, 09:00 ET

Vermillion to Present Corporate Overview at the Canaccord Genuity Medical Technology & Diagnostics Forum

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that Valerie Palmieri,...

Nov 12, 2015, 08:00 ET

Vermillion Reports Third Quarter 2015 Financial Results and Business Update

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported financial results for the third...

Nov 09, 2015, 09:00 ET

Vermillion Announces Decision by NICE to End MIB Pause for OVA1® Due to CE Mark of Overa®

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that the National...

Oct 29, 2015, 09:00 ET

Vermillion to Report Third Quarter 2015 Financial Results and Host Investor Conference Call on November 12

 Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, announced today it will report its third quarter...

Oct 26, 2015, 09:00 ET

Vermillion Announces CE Mark for Overa®, the Next Generation OVA1® Test

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced registration of the CE...

Oct 15, 2015, 09:00 ET

Vermillion to Present at the 2015 Achieving Optimal Health Conference in Conjunction with Company's Women's Outreach Programs

Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that it will present at the...

Sep 03, 2015, 09:00 ET

Vermillion Announces Dr. Herbert Fritsche as Recipient of the 2015 Abbott Award from the International Society of Oncology and Biomarkers

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that Herbert Fritsche,...

Sep 01, 2015, 16:01 ET

Vermillion Announces Launch of New Website in Conjunction with Ovarian Cancer Awareness Month

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today launched a new version of its...

Aug 19, 2015, 09:00 ET

Vermillion Announces Key Medical Policy Coverage for OVA1® Test

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced additional medical policy...

Aug 13, 2015, 09:00 ET

Vermillion Reports Second Quarter 2015 Financial Results and Business Update

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported financial results for the second...

Jul 30, 2015, 08:00 ET

Vermillion to Report Second Quarter 2015 Financial Results and Host Investor Conference Call on August 13

Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, announced today it will report its second quarter 2015...

Jul 17, 2015, 11:00 ET

Vermillion, Inc. Announces Closing of $18.8 Million Public Offering of Common Stock

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced the closing of an...

Jul 14, 2015, 09:00 ET

Vermillion, Inc. Prices $16.4 Million Public Offering of Common Stock

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced the pricing of an...

Jul 13, 2015, 16:01 ET

Vermillion, Inc. Announces Proposed Public Offering of Common Stock

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that it intends to offer...

Jul 13, 2015, 09:00 ET

ASPiRA Labs Receives New York State Permit

Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that its wholly owned...